---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-104109"
form_type: "8-K"
ticker: "ENTA"
cik: "0001177648"
company_name: "ENANTA PHARMACEUTICALS INC"
filed_at: "2026-03-12T23:59:59+00:00"
generated_at: "2026-05-15T12:57:19.515581+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Enanta stockholders approve 1.6M share increase to 2019 Equity Plan; re-elect directors

## Summary
- Stockholders re-elected Bruce L.A. Carter and Jay R. Luly as Class I directors with 20.3M and 24.7M votes for, respectively.
- Amendment to 2019 Equity Incentive Plan approved (19.5M for, 5.4M against), increasing share reserve by 1,600,000 shares.
- Advisory say-on-pay vote approved with 24.2M for, 692k against.
- Ratification of PricewaterhouseCoopers as independent auditor for fiscal 2026 approved (26.8M for, 27k against).

## SEC filing metadata
- accession: 0001193125-26-104109
- form_type: 8-K
- ticker: ENTA
- cik: 0001177648
- company_name: ENANTA PHARMACEUTICALS INC
- filed_at: 2026-03-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1177648/000119312526104109/0001193125-26-104109-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1177648/000119312526104109/enta-20260311.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-104109
- JSON: https://secwatch.observer/filing/0001193125-26-104109.json
- Plain text: https://secwatch.observer/filing/0001193125-26-104109.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.